ROS and superoxide decrease in the dormant form of mycobacteria. by Amar Yeware (7115063)

Depletion of EphA3 or EphA4 recovers the decreased ERK and Akt activation and lytic gene expression in RNF5 KO PEL cells. by Xiaojuan Li (351842)

Loss of either isoform of PLD decreases phagocytosis. by Wahida H. Ali (286470)

Virus replication is decreased by treatment of HDAC inhibitors. by Angelika Danielsson (229695)

“…<p>LNCaP and PC-346C were transduced with Ad[i/PPT-E1A, E3] and Ad5 wt and BON cells were transduced with Ad[CgA-E1A] and Ad5 wt. …”

Decrease in CLPs, NKPS and Block in NKP progression. by John Richards (53768)

Decrease of myopia progression with 0.025% atropine by Celso Marcelo da Cunha (4894324)

PI+ total immune cells are decreased at days 2, 5, and 14 following IR, and PI+ neutrophils are increased at day 30. by Jordan A. Gunning (18143970)

Decrease of ERK phosphorylation by NOS inhibitor TRIM. by Immacolata Castellano (603814)

Multiple miRNAs decrease telomerase activity. by Radmila Hrdličková (523455)

Knockdown of p65 in A549 cells results in a decreased infection rate. by Janine J. Wilden (8849948)

Spt5 protein is significantly decreased in <i>fog^sk8</i> embryos. by Keerthi Krishnan (269578)

“…(C–D) Whole mount immunofluorescence detection of Spt5 in WT and <i>fog^sk8</i> embryos at 24 hpf, showing overall decrease of Spt5 protein in <i>fog^sk8</i> embryos. …”

Decreased neutrophils in <i>MiR125a</i>^<i>-/-</i> mice. by Yuting Qin (1950118)

MES transiently decreases mitochondrial membrane potential. by Shingo Matsuyama (672132)

GSH content was decreased in low glucose conditions. by Martine Emery (215947)

Limiting Sox2 in endothelium decreases EndMTs and calcification in <i>Ins2</i>^{<i>Akita/+</i>} aortas. by Pierre J. Guihard (3391721)

“…<p>(a-b) Decreased expression of Sox2, stem cell and mesenchymal markers in aortas of <i>Cdh5</i>^<i>Cre</i><i>Sox2</i>^{<i>Flox/wt</i>}<i>Ins2</i>^{<i>Akita/+</i>}, as shown by real-time PCR (a) and immunoblotting (b). …”

(S12 Data). by Bianca Pellegrino (20314999)

B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

“…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”

Comparison of estimated arterial cerebral blood volumes (aCBVs) (Mean ± SD^*) between multiphase bSSFP and AVAST (N = 5). by Ki Hwan Kim (427869)

Reduced expression of Tks5 leads to decreased growth of tumor cells <i>in vitro</i> and <i>in vivo</i>. by Barbara Blouw (715467)

Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

“…Representative FACS staining is shown including quantification (n = 4–5 mice per group). (E) Laquinimod decreases pathogenic potential of T cells. …”